Comprehensive List of PKG Publication References
Resources
- Holly Woodrow, Malcolm K. Horne, Chathurini V. Fernando, Katya E. Kotschet and Treat to Target Study Group. A blinded, controlled trial of objective measurement in Parkinson’s disease. npj Parkinson’s Disease (2020) 6:35; https://doi.org/10.1038/s41531-020-00136-9
- H. Khodakarami, L. Ricciardi, M. Fiorella Contarino, R. Pahwa , K. E. Lyons, V. J. Geraedts, F. Morgante 2,6 , A. Leake, D. Paviour , A. De Angelis and M. Horne. Prediction of the Levodopa Challenge Test in Parkinson’s Disease Using Data from a Wrist-Worn Sensors (Basel) 2019 Nov 25;19(23):5153. doi: 10.3390/s19235153
- H. Khodakarami, P.Farzanehfar , M. Horne. The Use of Data from the Parkinson's KinetiGraph to Identify Potential Candidates for Device Assisted Therapies Sensors (Basel). 2019 May 15;19(10):2241. doi: 10.3390/s19102241.
- Rajesh Pahwa, Stuart H. Isaacson, Diego Torres-Russotto, Fatta B. Nahab, Peter M. Lynch & Katya E. Kotschet (2018): Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson’s disease: recommendations from an expert panel, Expert Review of Neurotherapeutics, DOI: 10.1080/14737175.2018.1503948
- Per Odin, K. Ray Chaudhuri,, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos and Filip Bergquist. Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease. npjParkinsonâ s Disease (2018) 4:14 ; doi:10.1038/s41531-018-0051-7
- Farzanehfar P, Woodrow H, Braybrook M, McGregor S, Evans A, Nicklason F, Horne M. Objective measurement in routine care of people with Parkinson’s disease improves outcomes. NPJ Parkinsons Dis. 2018 Apr 3;4:10. https://www.nature.com/articles/s41531-018-0046-4.
- Sarah McGregor, Philip Churchward , Katarzyna Soja, Denise O’Driscoll, Michelle Braybrook , Hamid Khodakarami, Andrew Evans, Parisa Farzanehfar, Garun Hamilton and Malcolm Horne. The use of accelerometry as a tool to measure disturbed nocturnal sleep in Parkinson’s disease. npj Parkinson's Disease (2018) 4:1 ; doi:10.1038/s41531-017-0038-9
- Parisa Farzanehfar & Malcolm Horne (2017) Evaluation of the Parkinson’s KinetiGraph in monitoring and managing Parkinson’s disease, Expert Review of Medical Devices, 14:8, 583-591, DOI: 10.1080/17434440.2017.1349608
- Malcolm Horne, Katya Kotschet and Sarah McGregor. The Clinical validation of objective Measurement of Movement in Parkinson’s Disease. CNS 2016: 2:(1). June 2016. Email info@globalkineticscorp.com.au for a copy
- Horne M, McGregor S, Bergquist F. 2015. An Objective Fluctuation Score for Parkinson’s Disease. PLOS One. Apr 2015. DOI:10.1371.
- Kotschet K, Johnson W, McGregor S, Kettlewell J, Kyoong A, O’Driscoll D.M, Turton A.R, Griffiths R.I. Horne M, 2014. Daytime sleep in Parkinson’s disease measured by episodes of immobility. Feb 2014. 1353-8020/ 2014 Elsevier Ltd. Email info@globalkineticscorp.com for a copy.
- Evans AH, Kettlewell J, McGregor 5, Kotschet K, Griffiths RI, et al. (2014) A Conditioned Response as a Measure of Impulsive-Compulsive Behaviours in Parkinson's Disease. PLoS ONE 9(2): e89319. doi:10.1371/journal.pone.0089319
- Filip Bergquist, Malcolm Horne. Can Objective Measurements Improve Treatment Outcomes in Parkinson’s Disease? European Neurological Review, 2014;9(1): Email info@globalkineticscorp.com.au for a copy
- Griffiths RI, Kotschet K, Arfon S, Xu ZM, Johnson W, Drago J, Evans A,Kempster P, Raghav S, Horne MK. Automated assessment of bradykinesia and dyskinesia in Parkinson’s disease. J Parkinsons Dis. 2012;2(1):47-55.
- P. Lynch, R. Pahwa, F. Bergquist, M. Horne. Objective Data in Parkinson’s Disease: A description of over 20,000 Parkinson’s symptom scores across the world using the Personal KinetiGraph (PKG) [abstract]. Mov Disord. 2018; 33 (suppl 2). http://www.mdsabstracts.org/abstract/objective-data-in-parkinsons-disease-a-description-of-over-20000-parkinsons-symptom-scores-across-the-world-using-the-personal-kinetigraph-pkg/. Accessed December 12, 2018
- Nahab FB, Abu-Hussain H, Moreno L. (2019) Evaluation of Clinical Utility of the Personal KinetiGraph in the Management of Parkinson’s Disease. Advances in Parkinson’s Disease, 8, 42-61. https://doi.org/10.4236/apd.2019.83005
- Joshi R, Bronstein JM, Alcazar J, Yang D, Joshi M, Hermanowicz N. An Observational Study of PKG Movement Recording System Use in Routine Clinical Care of Patients with Parkinson’s Disease. Movement Disorders Front. Neurol., 01 October 2019 | https://doi.org/10.3389/fneur.2019.01027
- Carroll C, Kobylecki C, Silverdale M, Thomas C. Impact of Quantitative Assessment of Parkinson’s Disease-Associated Symptoms Using Wearable Technology on Treatment Decisions. Journal of Parkinson’s Disease. DOI: 10.3233/JPD-191623. https://content.iospress.com/articles/journal-of-parkinsons-disease/jpd191623
- Erik Krause, Jaskaren Randhawa, Raja Mehanna. Comparing subjective and objective response to medications in Parkinson’s disease patients using the Personal KinetiGraph™. Parkinsonism and Related Disorders 87 (2021) 105–110